|
09/09/2024
|
07:01
|
Extension of Warrants in Incanthera to 31 Mar 2025
|
RNS
|
|
09/09/2024
|
07:00
|
Half-year Report
|
RNS
|
|
06/08/2024
|
13:41
|
Holding(s) in Company
|
RNS
|
|
28/06/2024
|
12:17
|
Result of AGM
|
RNS
|
|
06/06/2024
|
16:20
|
Holding(s) in Company
|
RNS
|
|
05/06/2024
|
14:01
|
Notice of AGM & Annual Report & Accounts
|
RNS
|
|
05/06/2024
|
07:00
|
Final Results
|
RNS
|
|
03/06/2024
|
10:09
|
Realisation-c£1.5m on sale of shares in Incanthera
|
RNS
|
|
03/05/2024
|
07:00
|
Holding(s) in Company
|
RNS
|
|
19/04/2024
|
07:00
|
Grant of Share Options
|
RNS
|
|
02/04/2024
|
07:03
|
New intellectual property strategy initiated
|
RNS
|
|
25/03/2024
|
07:25
|
Incanthera provides Comm'l Update/Revenue F'casts
|
RNS
|
|
19/03/2024
|
07:00
|
Grant of Share Options
|
RNS
|
|
06/03/2024
|
07:00
|
Financial, Business and Portfolio Develop't Update
|
RNS
|
|
28/12/2023
|
13:35
|
Holding(s) in Company
|
RNS
|
|
19/12/2023
|
14:50
|
Holding(s) in Company
|
RNS
|
|
19/12/2023
|
07:00
|
Simbec-Orion appointed as CRO
|
RNS
|
|
18/12/2023
|
07:15
|
Incanthera - Comm'l Skincare Deal/£1M Fundraise
|
RNS
|
|
13/09/2023
|
15:47
|
Holding(s) in Company
|
RNS
|
|
07/09/2023
|
07:00
|
Result of Retail Offer and Director Shareholding
|
RNS
|
|
31/08/2023
|
07:02
|
WRAP Retail Offer for up to £0.5m
|
RNS
|
|
31/08/2023
|
07:01
|
Subscription to raise £1.35m; Sharing Agr, RPT
|
RNS
|
|
31/08/2023
|
07:00
|
Interim results
|
RNS
|
|
21/08/2023
|
07:00
|
Extension of warrants in Incanthera plc
|
RNS
|
|
11/08/2023
|
12:04
|
Directorate Change
|
RNS
|
|
30/06/2023
|
13:12
|
Result of AGM
|
RNS
|
|
19/06/2023
|
07:00
|
Lupuzor Update
|
RNS
|
|
06/06/2023
|
07:00
|
IMM RNS Posting of RA and Notice of AGM 30 June 23
|
RNS
|
|
18/05/2023
|
07:00
|
Positive Pre-IND meeting with FDA
|
RNS
|
|
11/05/2023
|
07:00
|
Final Results
|
RNS
|
|
10/05/2023
|
13:56
|
Holding(s) in Company
|
RNS
|
|
19/04/2023
|
07:00
|
Lupozor Update - FDA confirms Type-C meeting date
|
RNS
|
|
12/04/2023
|
07:00
|
CIDP P140 Clinical Program Update
|
RNS
|
|
27/03/2023
|
07:00
|
Lupuzor™ Update
|
RNS
|
|
09/03/2023
|
16:35
|
Price Monitoring Extension
|
RNS
|
|
06/03/2023
|
07:00
|
Collaboration with Orano on ImmuPharma Peptide
|
RNS
|
|
06/02/2023
|
07:00
|
Lupuzor™ Update
|
RNS
|
|
27/01/2023
|
16:25
|
TR-1: Notification of major holdings
|
RNS
|
|
04/01/2023
|
17:26
|
TR-1: Notification of major holdings
|
RNS
|
|
04/01/2023
|
16:40
|
Second Price Monitoring Extn
|
RNS
|
|
04/01/2023
|
16:35
|
Price Monitoring Extension
|
RNS
|
|
03/01/2023
|
16:58
|
TR-1: Notification of major holdings
|
RNS
|
|
22/12/2022
|
07:55
|
Grant of Options
|
RNS
|
|
22/12/2022
|
07:00
|
End of Year Update
|
RNS
|
|
22/11/2022
|
15:15
|
Holding(s) in Company
|
RNS
|
|
14/11/2022
|
16:40
|
Second Price Monitoring Extn
|
RNS
|
|
14/11/2022
|
16:35
|
Price Monitoring Extension
|
RNS
|
|
11/11/2022
|
07:31
|
Lupuzor Update
|
RNS
|
|
11/10/2022
|
16:40
|
Second Price Monitoring Extn
|
RNS
|
|
11/10/2022
|
16:35
|
Price Monitoring Extension
|
RNS
|